Page last updated: 2024-08-24

ranitidine bismuth citrate and zithromax

ranitidine bismuth citrate has been researched along with zithromax in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnett, J; Chey, WD; Delvalle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Palaniappan, J; Scheiman, J1
Altintaş, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O1

Reviews

1 review(s) available for ranitidine bismuth citrate and zithromax

ArticleYear
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12

    Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Azithromycin; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine

1998

Trials

2 trial(s) available for ranitidine bismuth citrate and zithromax

ArticleYear
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12

    Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Azithromycin; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine

1998
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:2

    Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome

2004